Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
32,104,592
-
Shares change
-
-1,623,636
-
Total reported value, excl. options
-
$423,490,077
-
Value change
-
-$27,345,727
-
Number of buys
-
57
-
Number of sells
-
-35
-
Price
-
$13.19
Significant Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q4 2018
106 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q4 2018.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,104,592 shares
of 127,672,444 outstanding shares and own 25% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (4,502,498 shares), BlackRock Inc. (3,730,626 shares), Hillhouse Capital Advisors, Ltd. (2,229,708 shares), Sectoral Asset Management Inc (2,168,115 shares), Hillhouse Capital Management, Ltd. (2,098,581 shares), venBio Partners LLC (1,790,102 shares), Vanguard Group Inc (1,440,038 shares), VICTORY CAPITAL MANAGEMENT INC (1,387,763 shares), MILLENNIUM MANAGEMENT LLC (1,182,385 shares), and STATE STREET CORP (1,065,027 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.